'A generational wealth opportunity': 4 top Wall Street analysts share the cannabis stocks to buy now

As well, many institutions are locked out of the industry — meaning that these stocks are thinly traded relative to companies of a similar market value, and they have to contend with a high cost of capital, rapidly shifting regulations, and illicit market competition, among other roadblocks.Still, Wall Street's top cannabis analysts say there are companies that have separated themselves from the pack, based on their strong management teams and assets in lucrative state markets.Now is a good time to buy, given the recent pullback in the sector, analysts from JMP Securities said in a Thursday note."[W]e view the valuation reset and the consolidation of gains as healthy, but at the same time, creating an attractive longer-term entry point," the analysts said.Here are the four stocks that analysts picked as their favorites to invest in now:Company: Green Thumb Industries (GTBIF)Price target: $45Why it's a top pick: Azer has had the Chicago-based Green Thumb, or GTI, as her top cannabis stock pick for some time."The company has demonstrated the ability to drive strong top and bottom line performance from its core markets, which includes multiple consecutive quarters of positive net income and FCF (free cash flow)." Azer said in a June 10 note.Azer touted GTI's market-leading positions in Illinois and Pennsylvania, as well as the company's early presence in New Jersey and New York. Company: Curaleaf (CURLF) Price target: $26.50Why it's a top pick: In a May 11 note, Cantor Fitzgerald analyst Pablo Zuanic said that Curaleaf is his top pick among MSOs.Curaleaf acquired European cannabis giant EMMAC Life Sciences earlier this year, helping the firm expand throughout Europe.